Antacid Market to Grow at a CAGR of 4.0% to reach US$ 11,666.83 million from 2020 to 2027

Antacid Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Dosage Form (Tablet, Liquid, Others); Drug Class (Proton pump inhibitors, H2 Antagonist, Acid neutralizers); Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy) and Geography

Publication Month: Nov 2020 | Report Code: TIPRE00016359 | No. of Pages: 182 | Category: Pharmaceuticals | Status: Published
Covid

The antacid market is expected to reach US$ 11,666.83  million in 2027 from US$ 8,547.97  million in 2019. The market is estimated to grow with a CAGR of 4.0% from 2020-2027.

 

The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like  heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate. The global antacid market growth is mainly attributed to factors such as increasing prevalence of GERD, and rising prevalence of obesity. However, low awareness associated with gastrointestinal disorders in low-income economies is restricting the Antacid market growth.

 

Lucrative Regional Markets for Antacid

Get more information on this report :



Market Insights


Rise in Prevalence of Gastroesophageal Reflux Disease (GERD)

Gastroesophageal reflux disease (GERD), a digestive disorder that affects the ring of muscle between esophagus and stomach, is a chronic and highly prevalent disorder. As per the report ‘Update on the epidemiology of gastro-esophageal reflux disease: a systematic review’ published in 2014, the prevalence of GERD is 18.1–27.8% in North America, 2.5–7.8% in East Asia, 8.8–25.9% in Europe, 8.7–33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America.

 

Furthermore, the National GI Survey was conducted and completed in 2015 and was the first major attempt to measure the prevalence of GERD in the US since 2005. As per the survey, 18% of the 71,000 people reported episodes of GERD twice a week and 31% reported GERD episodes once a week.  The survey also reported that 35% of these patients used medications to control the condition and 55% of these used proton-pump inhibitors as their medication therapy. Additionally, the survey reported that the condition is more prevalent in women than in men. Thus, the factors mentioned above are driving the adoption of antacids during the forecast period

 

Dosage Form-Based Insights

The antacid market, by dosage form, is segmented into tablet, liquid, and others. The tablet segment held the largest share of the market in 2019, whereas the liquid segment is anticipated to register the highest CAGR  in the market during the forecast period. Factors such as availability of different types of antacid tablets, easy storage and accurate dosage are contributing to the growth of the segment.

 

Antacid Market, by Dosage Form – 2018 and 2027

Antacid Market, by Dosage Form – 2018 and 2027

Get more information on this report :


 

Drug Class -Based Insights

The antacid market, by drug class, is segmented into proton pump inhibitors, H2 antagonist, acid neutralizers. The proton pump inhibitors segment held the largest share of the market in 2019, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

 

Distribution Channel - Based Insights

Based on distribution channel, the antacid market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment held the largest share of the market in 2019. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period.

 

Strategic Insights

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios; these strategies help them meet the growing consumer demand. Collaboration is one of the major strategies adopted by the Antacid market players to enlarge customer base worldwide, which also permits them to maintain their brand name globally.

 

Global Antacid Market – by Dosage Form

  • Tablet
  • Liquid
  • Others


Global Antacid Market – by Drug Class

  • Proton pump inhibitors
  • H2 Antagonist
  • Acid neutralizers


Global Antacid Market – by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy


Antacid Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
  • South and Central America
    • Brazil
    • Argentina
    • Rest of South America

 

Company Profiles

  • Bayer AG
  • GlaxoSmithKline plc.
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Procter & Gamble

 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Antacid Market – By Dosage Form

1.3.2        Antacid Market – By Drug Class

1.3.3        Antacid Market – By Distribution Channel

1.3.4        Global Antacid Market – By Geography

2.             Antacid Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Antacids– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East and Africa (MEA) – PEST Analysis

4.2.5        South and Central America (SCAM) – PEST Analysis

4.3       Expert Opinions

5.             Antacid Market– Key Market Dynamics

5.1       Market Drivers

5.1.1        Rise in Prevalence of Gastroesophageal Reflux Disease (GERD)

5.1.2        Increase in Prevalence of Obesity

5.2       Market Restraints

5.2.1        Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies

5.3       Market Opportunities

5.3.1        Increasing Research Activities and Research Funds on GI Disorders

5.4       Future Trends

5.4.1        Development and Launch of Innovative Products

5.5       Impact Analysis

6.             Antacid Market – Global Analysis

6.1       Global Antacid Market Revenue Forecast And Analysis

6.2       Global Antacid Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Antacid Market Analysis – By Dosage Form

7.1       Overview

7.2       Antacid Market Revenue Share, by Dosage Form (2019 and 2027)

7.3       Tablet

7.3.1        Overview

7.3.2        Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

7.4       Liquid

7.4.1        Overview

7.4.2        Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

7.5       Others

7.5.1        Overview

7.5.2        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.             Antacid Market Analysis – By Drug Class

8.1       Overview

8.2       Antacid Market Revenue Share, by Drug Class (2019 and 2027)

8.3       Proton Pump Inhibitors

8.3.1        Overview

8.3.2        Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.4       H? Antagonist

8.4.1        Overview

8.4.2        H? Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Acid Neutralizers

8.5.1        Overview

8.5.2        Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.3        Magaldrate

8.5.3.1      Overview

8.5.3.2      Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.4        Sucralfate

8.5.4.1      Overview

8.5.4.2      Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.5        Others

8.5.5.1      Overview

8.5.5.2      Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.             Antacid Market Analysis – By Distribution Channel

9.1       Overview

9.2       Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)

9.3       Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.4       Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.5       Online Pharmacy

9.5.1        Overview

9.5.2        Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

10.          Antacid Market – Geographic Analysis

10.1    North America: Antacid Market

10.1.1     Overview

10.1.2     North America: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     North America: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.4     North America: Antacid Market, by Drug Class, 2018–2027 (USD Million)

10.1.4.1    North America: Acid Neutralizers Market, by Type, 2018–2027 (USD Million)

10.1.5     North America: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.6     North America: Antacid Market, by Country, 2019 & 2027 (%)

10.1.7     US: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1    US: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2    US: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.7.3    US: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.7.3.1    US: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.7.4    US: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.8     Canada: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1    Canada: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2    Canada: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.8.3    Canada: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.8.3.1    Canada: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.8.4    Canada: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.9     Mexico: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1    Mexico: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2    Mexico: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.9.3    Mexico: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.9.3.1    Mexico: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.9.4    Mexico: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.2    Europe: Antacid Market

10.2.1     Overview

10.2.2     Europe: Antacid Market - Revenue and Forecast to 2027 (USD Million)

10.2.3     Europe: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.2.4     Europe: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.2.4.1    Europe: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.2.5     Europe: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.2.6     Europe: Antacid Market, by Country, 2019 & 2027 (%)

10.2.7     Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.1    Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.2    Germany: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.2.7.3    Germany: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.2.7.3.1    Germany: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.2.7.4    Germany: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.2.8     UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.1    UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.2    UK: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.2.8.3    UK: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.2.8.3.1    UK: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.2.8.4    UK: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.2.9     France: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.1    France: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.2    France: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.2.9.3    France: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.2.9.3.1    France: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.2.9.4    France: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.2.10   Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.1 Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.2 Spain: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.2.10.3 Spain: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.2.10.3.1 Spain: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.2.10.4 Spain: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.2.11   Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.1 Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.2 Italy: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.2.11.3 Italy: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.2.11.3.1 Italy: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.2.11.4 Italy: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.2.12   Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.12.1 Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.2.12.2 Rest of Europe: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.2.12.3 Rest of Europe: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.2.12.3.1 Rest of Europe: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.2.12.4 Rest of Europe: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.3    Asia-Pacific: Antacid Market

10.3.1     Overview

10.3.2     Asia-Pacific: Antacid Market,- Revenue and Forecast to 2027 (USD Million)

10.3.3     Asia-Pacific: Antacid Market, by Dosage Form– Revenue and Forecast to 2027 (USD Million)

10.3.4     Asia-Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.3.4.1    Asia-Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.3.5     Asia-Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.6     Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)

10.3.7     China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)

10.3.7.1    China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)

10.3.7.2    China: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.3.7.3    China: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.3.7.3.1    China: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.3.7.4    China: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.8     Japan: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.1    Japan: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.2    Japan: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.3.8.3    Japan: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.3.8.3.1    Japan: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.3.8.4    Japan: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.9     India: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.1    India: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.2    India: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.3.9.3    India: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.3.9.4    India: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.3.9.5    India: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.10   South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.1 South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.2 South Korea: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.3.10.3 South Korea: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.3.10.3.1 South Korea: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.3.10.4 South Korea: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.11   Australia: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.1 Australia: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.2 Australia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.3.11.3 Australia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.3.11.3.1 Australia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.3.11.4 Australia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.3.12   Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.3.12.1 Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.3.12.2 Rest of Asia Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.3.12.3 Rest of Asia Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.3.12.4 Rest of Asia Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.3.12.5 Rest of Asia Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.4    Middle East & Africa: Antacid Market

10.4.1     Overview

10.4.2     Middle East & Africa: Antacid Market - Revenue and Forecast to 2027 (US$ Million)

10.4.3     Middle East & Africa: Antacid Market, by Dosage Form– Revenue and Forecast to 2027 (USD Million)

10.4.4     Middle East & Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.4.4.1    Middle East & Africa: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.4.5     Middle East & Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

10.4.6     Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)

10.4.7     Saudi Arabia: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.1    Saudi Arabia: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.2    Saudi Arabia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.4.7.3    Saudi Arabia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.4.7.3.1    Saudi Arabia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.4.7.4    Saudi Arabia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.4.8     UAE: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.1    UAE: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.2    UAE: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.4.8.3    UAE: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.4.8.4    UAE: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.4.8.5    UAE: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.4.9     South Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.4.9.1    South Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.4.9.2    South Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.4.9.3    South Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.4.9.4    Asia-Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.4.9.5    South Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.4.10   Rest of Middle East and Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.4.10.1 Rest of Middle East and Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.4.10.2 Rest of Middle East and Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.4.10.3 Rest of Middle East and Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.4.10.4 Asia-Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

10.4.10.5 Rest of Middle East and Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

10.5    South and Central America: Antacid Market

10.5.1     Overview

10.5.2     South and Central America: Antacid Market - Revenue and Forecast to 2027 (USD Million)

10.5.3     South and Central America: Antacid Market, by Dosage Form – Revenue and Forecast to 2027  (USD Million)

10.5.4     South and Central America: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.5.4.1    South and Central America: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.5     South and Central America: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.5.6     South and Central America: Antacid Market, by Country, 2019 & 2027 (%)

10.5.7     Brazil: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.1    Brazil: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.2    Brazil: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.5.7.3    Brazil: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.5.7.3.1    Brazil: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.7.4    Brazil: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.5.8     Argentina: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.1    Argentina: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.2    Argentina: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

10.5.8.3    Argentina: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.5.8.3.1    Argentina: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.8.4    Argentina: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.5.9     Rest of South and Central America: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.5.9.1    Rest of South and Central America: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.5.9.2    Rest of South and Central America: Antacid Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

10.5.9.3    Rest of South and Central America: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

10.5.9.3.1    Rest of South and Central America: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.5.9.4    Rest of South and Central America: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.          Impact of COVID-19 Pandemic on Global Antacid Market

11.1    North America: Impact Assessment of COVID-19 Pandemic

11.2    Europe: Impact Assessment of COVID-19 Pandemic

11.3    Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

12.          Antacid Market– Industry Landscape

12.1    Overview

12.2    Growth Strategies Done by the Companies in the Market, (%)

12.3    Organic Developments

12.3.1     Overview

12.4    Inorganic Developments

12.4.1     Overview

13.          Company Profiles

13.1    Bayer AG

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Takeda Pharmaceutical Company Limited

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Sun Pharmaceutical Industries Ltd

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Sanofi

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Boehringer Ingelheim International GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Dr. Reddy's Laboratories

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    Pfizer Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     roducts and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Reckitt Benckiser Group Plc

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Procter & Gamble

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    Glossary of Terms

LIST OF TABLES

Table 1.             North America Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.             US Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 6.             US Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 7.             US Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 8.             US Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.             Canada Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 10.          Canada Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Mexico Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 14.          Mexico Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 15.          Mexico Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.          Europe Antacid Market, by Dosage Form– Revenue and Forecast to 2027 (USD Million)

Table 18.          Europe Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 19.          Europe Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 20.          Europe Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.          Germany Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 22.          Germany Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 23.          Germany Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 24.          Germany Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 25.          UK Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 26.          UK Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 27.          UK Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 28.          UK Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 29.          France Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 30.          France Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 31.          France Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 32.          France Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 33.          Spain Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 34.          Spain Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 35.          Spain Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 36.          Spain Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 37.          Italy Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 38.          Italy Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 39.          Italy Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 40.          Italy Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 41.          Rest of Europe Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 42.          Rest of Europe Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 43.          Rest of Europe Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 44.          Rest of Europe Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 45.          Asia-Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 46.          Asia-Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 47.          Asia-Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 48.          Asia-Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 49.          China: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 50.          China: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 51.          China: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 52.          China: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 53.          Japan: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 54.          Japan: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 55.          Japan: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 56.          Japan: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 57.          India: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 58.          India: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 59.          India: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 60.          India: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 61.          South Korea: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 62.          South Korea: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 63.          South Korea: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 64.          South Korea: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 65.          Australia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 66.          Australia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 67.          Australia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 68.          Australia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 69.          Rest of Asia Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 70.          Rest of Asia Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 71.          Rest of Asia Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 72.          Rest of Asia Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 73.          Middle East & Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 74.          Middle East & Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 75.          Middle East & Africa: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 76.          Middle East & Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 77.          Saudi Arabia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 78.          Saudi Arabia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 79.          Saudi Arabia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 80.          Saudi Arabia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 81.          UAE: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 82.          UAE: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 83.          UAE: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 84.          UAE: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 85.          South Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 86.          South Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 87.          South Africa Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)

Table 88.          South Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 89.          Rest of Middle East and Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 90.          Rest of Middle East and Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 91.          Rest of Middle East and Africa Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027  (USD Million)

Table 92.          Rest of Middle East and Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 93.          South and Central America: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 94.          South and Central America: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 95.          South and Central America: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 96.          South and Central America: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 97.          Brazil: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 98.          Brazil: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 99.          Brazil: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 100.       Brazil: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 101.       Argentina: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 102.       Argentina: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 103.       Argentina: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 104.       Argentina: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 105.       Rest of South and Central America: Antacid Market, by Therapeutic – Revenue and Forecast to 2027  (USD Million)

Table 106.       Rest of South and Central America: Antacid Market, by Drug Class – Revenue and Forecast to 2027  (USD Million)

Table 107.       Rest of South and Central America: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 108.       Rest of South and Central America: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 109.       Organic Developments Done By Companies

Table 110.       Inorganic Developments Done By Companies

Table 111.       Glossary of Terms, Antacid Market

 

LIST OF FIGURES

Figure 1.           Antacid Market Segmentation

Figure 2.           Antacid Market – By Geography

Figure 3.           Antacid Market Overview

Figure 4.           Liquid to Witness Rapid Growth of Antacid Market

Figure 5.           Asia Pacific to Show Significant Growth During Forecast Period

Figure 6.           Antacid Market, by Geography (US$ Million)

Figure 7.           Global Antacid Market – Leading Country Markets (US$ Million)

Figure 8.           Global Antacid Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East and Africa (MEA) PEST Analysis

Figure 13.        South and Central America (SCAM) PEST Analysis

Figure 14.        Antacid Market Impact Analysis of Drivers and Restraints

Figure 15.        Global Antacid Market – Revenue Forecast And Analysis – 2019- 2027

Figure 16.        Global Antacid Market – By Geography Forecast and Analysis – 2019- 2027

Figure 17.        Market Positioning Of Key Players In Global Antacid Market

Figure 18.        Antacid Market Revenue Share, by Dosage Form (2019 and 2027)

Figure 19.        Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Antacid Market Revenue Share, by Drug Class (2019 and 2027)

Figure 23.        Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        H? Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 30.        Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33.        North America: Antacid Market, by Key Country – Revenue (2019) (USD Million)

Figure 34.        North America Antacid Market Revenue and Forecast to 2027 (USD Million)

Figure 35.        North America: Antacid Market, by Country, 2019 & 2027 (%)

Figure 36.        US: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Canada: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Mexico: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 39.        Europe: Antacid Market, by Key Country – Revenue (2019) (USD Million)

Figure 40.        Europe Antacid Market Revenue and Forecast to 2027 (USD Million)

Figure 41.        Europe: Antacid Market, by Country, 2019 & 2027 (%)

Figure 42.        Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 43.        UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 44.        France: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 45.        Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 46.        Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 47.        Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 48.        Asia-Pacific: Antacid Market, by Key Country – Revenue (2019) (USD Million)

Figure 49.        Asia-Pacific: Antacid Market, Revenue and Forecast to 2027 (USD Million)

Figure 50.        Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)

Figure 51.        China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)

Figure 52.        Japan Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 53.        India: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 54.        South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 55.        Australia: Antacid – Revenue and Forecast to 2027 (USD Million)

Figure 56.        Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 57.        Middle East & Africa: Antacid Market, by Key Country – Revenue (2019) (USD Million)

Figure 58.        Middle East & Africa Antacid Market –Revenue and Forecast to 2027 (USD Million)

Figure 59.        Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)

Figure 60.        Saudi Arabia: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 61.        UAE: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 62.        South Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 63.        Rest of Middle East and Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 64.        South and Central America: Antacid Market , by Key Country – Revenue (2019) (USD Million)

Figure 65.        South and Central America: Antacid Market, Revenue and Forecast to 2027 (USD Million)

Figure 66.        South and Central America: Antacid Market, by Country, 2019 & 2027 (%)

Figure 67.        Brazil: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 68.        Argentina: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 69.        Rest of South and Central America: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 70.        Impact of COVID-19 Pandemic on Antacid Market in North American Countries

Figure 71.        Impact of COVID-19 Pandemic on Antacid Market in European Countries

Figure 72.        Impact of COVID-19 Pandemic on Antacid Market in Asia Pacific Countries

Figure 73.        Impact of COVID-19 Pandemic on Antacid Market in Rest of the World

Figure 74.        Growth Strategies Done by the Companies in the Market

 

The List of Companies - Antacid Market

  1. Bayer AG
  2. GlaxoSmithKline plc.
  3. Takeda Pharmaceutical Company Limited
  4. Sun Pharmaceutical Industries Ltd
  5. Sanofi
  6. Boehringer Ingelheim International GmbH
  7. Dr. Reddy's Laboratories
  8. Pfizer Inc.
  9. Reckitt Benckiser Group Plc
  10. Procter & Gamble
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the antacid market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global antacid market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00016359
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing